Association between bevacizumab-related hypertension and response to treatment in patients with metastatic colorectal cancer

BACKGROUND: Bevacizumab has become standard of care as first-line treatment of metastatic colorectal cancer (mCRC), after proving increased response rates and improvement in survival outcomes. Hypertension (HTN) is a common complication of the treatment with bevacizumab and, owing to its close relat...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:ESMO Open
Autores principales: Dionísio de Sousa, Isabel José, Ferreira, Joana, Rodrigues, Joana, Bonito, Nuno, Jacinto, Paula, Marques, Mariela, Ribeiro, João, Pais, Ana, Gervásio, Helena
Formato: Artigo
Lenguaje:Inglês
Publicado: BMJ Publishing Group 2016
Materias:
Original Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5070256/
https://ncbi.nlm.nih.gov/pubmed/27843607
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/esmoopen-2016-000045
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares